Diclofenac Epolamine System
Product Images NDC 83008-036

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclofenac Epolamine (NDC 83008-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quality Care Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (1)

Label for Diclofenac Epolamine Topical System 1.3%, distributed by Quality Care Products, LLC. The package contains 30 topical systems, each measuring 10 cm by 14 cm. The label indicates prescription use and storage instructions at 68 to 77 degrees Fahrenheit. It includes manufacturer information for IBSA Institut Biochimique SA, Switzerland, and Altergon Italia Srl, Italy.*

FDA Label Image

Chemical Structure (Diclofenac 01)

Chemical structure diagram depicting the active ingredient diclofenac epolamine, including the diclofenac moiety and the epolamine component labeled as 2-(pyrrolidin-1-yl)ethanol.*

FDA Label Image

Figure 1 And 2 (Diclofenac 02)

Two line graphs showing patients achieving various levels of pain relief in a 14-day study. Figure 1 presents data at Day 3, and Figure 2 at the end of the study. Both graphs compare percent improvement from baseline in patients using a diclofenac patch versus placebo, with the diclofenac patch group consistently showing higher percentages of patients improved across different improvement levels.*

FDA Label Image

Figure 3 And 4 (Diclofenac 03)

Two line graphs from a 7-day study showing the percentage of patients achieving various levels of pain relief using diclofenac epolamine patch versus placebo. The left graph depicts results at day 3, with higher percentages of patients improved across increasing levels of percent improvement from baseline for the diclofenac patch compared to placebo. The right graph shows similar data at the end of the study, with the diclofenac patch maintaining higher patient improvement percentages than placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.